Related Experiment Video
Updated: Mar 20, 2026
05:17
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
2.1K
Noscapine and its Analogs as Chemotherapeutic Agent: Current updates
Vartika Tomar, Shrikant Kukreti, Satya Prakash
1Department of Chemistry, University of Delhi, Delhi - 110007, India.
Current Topics in Medicinal Chemistry
|May 31, 2016
Summary
Noscapine, a microtubule-targeting agent, shows promise as a safe and effective anticancer drug with potential preventive applications. Its low toxicity and broad efficacy against resistant cancers warrant further investigation for therapeutic development.
Area of Science:
- Pharmacology
- Oncology
- Biotechnology
Background:
- Noscapine is an emerging anticancer agent that interacts with microtubules differently than traditional chemotherapeutics.
- Existing microtubule-targeting drugs like colchicine and podophyllotoxin have significant toxicities and resistance issues.
- Noscapine and its analogs exhibit a favorable safety profile, lacking neurotoxicity and immunosuppression.
Purpose of the Study:
- To review current research and patents on noscapine and its derivatives (noscapinoids) as potential therapeutic agents.
- To highlight the unique mechanism of action and low toxicity of noscapine compared to other microtubule agents.
- To explore the potential of noscapine in cancer chemotherapy, neuroprotection, and preventive medicine.
Main Methods:
- Review of recent scientific literature and patent filings concerning noscapine and its analogs.
- Characterization of structural properties of novel analogs like 9-bromo noscapine and Red-9-Br-Nos.
- Analysis of preclinical data on noscapine's efficacy in cancer models and its neuroprotective and anti-inflammatory effects.
Main Results:
- Noscapine mitigates microtubule dynamics without depolymerization, offering a distinct mechanism from toxic chemotherapeutics.
- Noscapine demonstrates efficacy against resistant cancers, such as taxane-resistant ovarian cancer.
- Noscapine and its analogs exhibit neuroprotective and anti-inflammatory activities, with potential preventive uses in ischemia-reperfusion injury and fibrosis.
- The complete biosynthetic pathway of noscapine is identified, enabling biotechnological production.
Conclusions:
- Noscapine and its derivatives (noscapinoids) represent promising, cost-effective, and safe candidates for cancer chemotherapy.
- The low toxicity profile of noscapine suggests potential applications in preventive medicine for high-risk individuals.
- Further research and development of noscapinoids could lead to novel therapeutic strategies with reduced side effects.
More Related Videos
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
14.5K
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
19.3K
Related Concept Videos
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
726
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
726
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.0K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.0K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
926
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
926
01:15Anthelminthic Agents
11
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
11
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
786
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
786
01:10Drugs that Destabilize Microtubules
4.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K